Clinical Trial Update: Involvement of Endogenous Digitalis-like Compounds in Breast Cancer

View source ↗

Summary

Clinical trial NCT00310882 has been withdrawn; it investigated the involvement of endogenous digitalis-like compounds in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Fibrocystic Breast Disease

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Breast Neoplasms, Fibrocystic Disease of Breast | Status: WITHDRAWN